Dr. Reddy's Laboratories' API manufacturing plant at Srikakulam in state of Andhra Pradesh has been audited by the US Food and Drug Administration (USFDA), and the audit has been completed on April 4, 2017. The company has been issued a Form 483 with 2 observations, which it is addressing.

Total volume of shares traded on the bourses today was higher by 23.83% to 716,758 compared with 22-day average volume of 578,809.

Shares of the company declined Rs 16.2, or 0.59%, to trade at Rs 2,730.00. The total volume of shares traded was 28,329 at the BSE (10.24 a.m., Wednesday).